Johnson Matthey PLC (LON:JMAT – Get Free Report) shares reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 1,289 ($16.74) and last traded at GBX 1,308 ($16.98), with a volume of 1724131 shares traded. The stock had previously closed at GBX 1,334 ($17.32).
Analyst Ratings Changes
Separately, Jefferies Financial Group reiterated a “buy” rating and issued a GBX 1,800 ($23.37) price objective on shares of Johnson Matthey in a report on Tuesday, December 17th.
View Our Latest Analysis on Johnson Matthey
Johnson Matthey Stock Performance
Insiders Place Their Bets
In other news, insider Liam Condon purchased 27 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The stock was bought at an average price of GBX 1,445 ($18.76) per share, for a total transaction of £390.15 ($506.62). Insiders acquired a total of 84 shares of company stock worth $119,052 over the last 90 days. Corporate insiders own 0.61% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Stories
- Five stocks we like better than Johnson Matthey
- Stock Dividend Cuts Happen Are You Ready?
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- How to Use the MarketBeat Stock Screener
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Insider Trading – What You Need to Know
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.